RECALL ALERT: Birth control pill recalled due to risk of contraceptive failure

A Baltimore-based company is recalling some of its birth control pills, due to the risk of contraceptive failure, according to the FDA.

According to an FDA statement, Lupin Pharmaceuticals Inc. is recalling a specific lot of its Mibelas 24 Fe tablets. The lot affected has the lot number of L600518, with an expiry date of May 31, 2018. A market complaint, which has reportedly been confirmed, indicate that a packaging error has rotated the blister 180 degrees within the wallet, which reverses the weekly tablet orientation, and meant those on the first four days of therapy would have had the four non-hormonal placebo tablets, instead of the active tablets.

FDA officials said as a result, oral contraceptive tablets that are taken out of sequence could place the user at risk of contraceptive failure and unintended pregnancy. Lupin, according to the statement, is notifying its distributors and customers by recall letter, and is arranging for the return of all recalled products. Those who have the affected product should notify their physician, and return the product to the pharmacy, or to the place of purchase.

Those with questions can call Lupin Pharmaceuticals at 1-800-399-2561, from 8:00 a.m. to 5:00 p.m. (Eastern Time), Monday through Friday.

Up Next:

Up Next

  • RECALL ALERT: Birth control pill recalled due to risk of contraceptive failure
  • Report: 99 percent of NFL players in study had CTE
  • Smarter dummies could make cars safer
  • Company offering employees microchip implants
  • Rise in child Baker Act cases prompts meeting at capitol
  • Hotline helps Floridians get money owed by insurance
  • Doctor accused of telling well patients they had cancer
  • FDA panel recommends approval of gene altering therapy to fight cancer
  • Forest Bathing: A stress cleanse
  • Are fizzy drinks harmful for your teeth?